{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:44:15Z","timestamp":1777416255769,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.cmi.2014.11.020","type":"journal-article","created":{"date-parts":[[2014,12,22]],"date-time":"2014-12-22T14:09:38Z","timestamp":1419257378000},"page":"222-225","source":"Crossref","is-referenced-by-count":43,"title":["Neuraminidase inhibitors: who, when, where?"],"prefix":"10.1016","volume":"21","author":[{"given":"J.S.","family":"Nguyen-Van-Tam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.G.","family":"Muthuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.R.","family":"Myles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2014.11.020_bib1","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/oxfordjournals.aje.a116184","article-title":"Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2)","volume":"134","author":"Mast","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cmi.2014.11.020_bib2","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/516358","article-title":"Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults","volume":"26","author":"Englund","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2014.11.020_bib3","unstructured":"Summary of Product Characteristics (SPC), Lysovir 100mg capsules (amantadine hydrochloride). Available at: https:\/\/www.medicines.org.uk\/emc\/medicine\/2496. [last accessed 31.10.14]."},{"key":"10.1016\/j.cmi.2014.11.020_bib4","unstructured":"Summary of Product Characteristics (SPC), Tamiflu 75mg hard capsules (oseltamivir phosphate). Available at: https:\/\/www.medicines.org.uk\/emc\/medicine\/10446. [last accessed 31.10.14]."},{"key":"10.1016\/j.cmi.2014.11.020_bib5","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.163.14.1667","article-title":"Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations","volume":"163","author":"Kaiser","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cmi.2014.11.020_bib6","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1086\/444508","article-title":"Accuracy of clinical diagnosis of influenza in outpatient children","volume":"41","author":"Peltola","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2014.11.020_bib7","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1155\/2013\/762140","article-title":"Influenza infection screening tools fail to accurately predict influenza status for patients during pandemic H1N1 influenza season","volume":"20","author":"Mulpuru","year":"2013","journal-title":"Can Respir J"},{"key":"10.1016\/j.cmi.2014.11.020_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1750-2659.2012.00398.x","article-title":"Diagnosing swine flu: the inaccuracy of case definitions during the 2009 pandemic, an attempt at refinement, and the implications for future planning","volume":"7","author":"Mahony","year":"2013","journal-title":"Influenza Other Respir Virus."},{"key":"10.1016\/j.cmi.2014.11.020_bib9","unstructured":"National Institute for Health and Care Excellence. Amantadine, oseltamivir and zanamivir for the treatment of influenza (TA168). Available at: http:\/\/www.nice.org.uk\/guidance\/TA168. [last accessed 31.10.14]."},{"key":"10.1016\/j.cmi.2014.11.020_bib10","unstructured":"World Health Organization. Responding to the avian influenza pandemic threat. Recommended strategic actions. Available at: http:\/\/www.who.int\/csr\/resources\/publications\/influenza\/WHO_CDS_CSR_GIP_05_8-EN.pdf. [last accessed 31.10.14]."},{"key":"10.1016\/j.cmi.2014.11.020_bib11","first-page":"CD008965","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children (Review)","volume":"4","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2014.11.020_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data","volume":"2","author":"Muthuri","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2014.11.020_bib13","unstructured":"Summary of Product Characteristics (SPC), Relenza 5mg inhalation powder (zanamivir). Available at: https:\/\/www.medicines.org.uk\/emc\/medicine\/2608. [last accessed 31.10.14]."},{"key":"10.1016\/j.cmi.2014.11.020_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)62449-1","article-title":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials","author":"Dobson","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2014.11.020_bib15","doi-asserted-by":"crossref","first-page":"c221","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: conduct, rationale and reporting","volume":"340","author":"Riley","year":"2010","journal-title":"Br Med J"},{"key":"10.1016\/j.cmi.2014.11.020_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/jis726","article-title":"Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009\u20132010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients","volume":"207","author":"Muthuri","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.cmi.2014.11.020_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/bja\/aet290","article-title":"Demystifying propensity scores","volume":"112","author":"Okoli","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.cmi.2014.11.020_bib18","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"Br Med J"},{"key":"10.1016\/j.cmi.2014.11.020_bib19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cmi.2014.11.020_bib20","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/S2213-2600(14)70137-7","article-title":"Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality","volume":"2","author":"Leonardi-Bee","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2014.11.020_bib21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3201\/eid1408.070751","article-title":"Bacterial pneumonia and pandemic influenza planning","volume":"14","author":"Gupta","year":"2008","journal-title":"Emerg Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14001062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14001062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T16:23:09Z","timestamp":1537978989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14001062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1198743X14001062"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2014.11.020","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}